Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 2532839)

Published in Mol Endocrinol on August 24, 2006

Authors

Sarah C Roemer1, Douglas C Donham, Lori Sherman, Vickie H Pon, Dean P Edwards, Mair E A Churchill

Author Affiliations

1: Program in Molecular Biology, Department of Pharmacology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA.

Articles citing this

DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (2009) 4.48

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47

Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr Rev (2012) 1.11

Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model. Proc Natl Acad Sci U S A (2007) 1.06

Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4alpha. Diabetes gene product. J Biol Chem (2008) 1.04

The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol Endocrinol (2010) 1.01

Interaction of estrogen receptor alpha with proliferating cell nuclear antigen. Nucleic Acids Res (2007) 1.01

Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function. Proc Natl Acad Sci U S A (2007) 0.98

Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Expr (2008) 0.97

Activation of PPARδ: from computer modelling to biological effects. Br J Pharmacol (2014) 0.97

A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J Biol Chem (2009) 0.96

Structural and functional analysis of domains of the progesterone receptor. Mol Cell Endocrinol (2011) 0.95

Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res (2008) 0.94

Progesterone receptors, their isoforms and progesterone regulated transcription. Mol Cell Endocrinol (2011) 0.92

Evolution of DNA specificity in a transcription factor family produced a new gene regulatory module. Cell (2014) 0.92

Understanding nuclear receptor form and function using structural biology. J Mol Endocrinol (2013) 0.91

Glucocorticoid receptor-promoter interactions: energetic dissection suggests a framework for the specificity of steroid receptor-mediated gene regulation. Biochemistry (2012) 0.91

Retinoic acid actions through mammalian nuclear receptors. Chem Rev (2013) 0.90

ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors. Mol Endocrinol (2009) 0.88

Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain. PLoS One (2011) 0.86

General molecular biology and architecture of nuclear receptors. Curr Top Med Chem (2012) 0.84

Novel DNA-binding element within the C-terminal extension of the nuclear receptor DNA-binding domain. Nucleic Acids Res (2007) 0.84

Thermodynamic dissection of estrogen receptor-promoter interactions reveals that steroid receptors differentially partition their self-association and promoter binding energetics. Biochemistry (2012) 0.83

Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol (2011) 0.83

Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding. J Biol Chem (2013) 0.82

Differential and interactive effects of ligand-bound progesterone receptor A and B isoforms on tyrosine hydroxylase promoter activity. J Neuroendocrinol (2011) 0.81

Transcription factor family-specific DNA shape readout revealed by quantitative specificity models. Mol Syst Biol (2017) 0.79

Analysis of a glucocorticoid-estrogen receptor chimera reveals that dimerization energetics are under ionic control. Biophys Chem (2012) 0.77

Single nucleotide changes in the human Igamma1 and Igamma4 promoters underlie different transcriptional responses to CD40. J Immunol (2009) 0.76

Efficient prediction of progesterone receptor interactome using a support vector machine model. Int J Mol Sci (2015) 0.75

Articles cited by this

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol (1994) 37.96

The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68

The nuclear receptor superfamily: the second decade. Cell (1995) 24.99

The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. J Biomol Struct Dyn (1988) 9.26

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (1991) 7.46

A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res (1990) 5.42

Functional domains of the human glucocorticoid receptor. Cell (1986) 4.68

Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23

SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res (2004) 4.09

Protein-DNA interactions: A structural analysis. J Mol Biol (1999) 3.38

Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (1995) 3.32

The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell (1993) 2.95

Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev (1994) 2.78

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol (1998) 2.38

Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science (1992) 2.08

The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol (1993) 1.98

Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A (2004) 1.97

Steroid hormone receptors: an update. Hum Reprod Update (2000) 1.90

DNA analysis servers: plot.it, bend.it, model.it and IS. Nucleic Acids Res (2003) 1.70

Nuclear-receptor interactions on DNA-response elements. Trends Biochem Sci (2001) 1.60

Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science (1993) 1.56

Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J (2000) 1.46

Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J (1994) 1.46

Anatomy of the steroid receptor zinc finger region. Endocr Rev (1992) 1.44

Structural determinants of a glucocorticoid receptor recognition element. Mol Endocrinol (1990) 1.44

The structural basis of DNA flexibility. Philos Trans A Math Phys Eng Sci (2004) 1.33

Structural elements of an orphan nuclear receptor-DNA complex. Mol Cell (1998) 1.31

HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol (1999) 1.31

Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol Endocrinol (1999) 1.28

Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J Mol Biol (2003) 1.24

Structural determinants of DNA-binding specificity by steroid receptors. Mol Endocrinol (1995) 1.22

Structural basis of RXR-DNA interactions. J Mol Biol (2000) 1.22

DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B. Nat Struct Biol (1999) 1.20

Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids (1999) 1.15

Characterization of the response element and DNA binding properties of the nuclear orphan receptor germ cell nuclear factor/retinoid receptor-related testis-associated receptor. J Biol Chem (1997) 1.15

Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides: retention prediction. J Chromatogr A (2002) 1.12

Rapid atomic density methods for molecular shape characterization. J Mol Graph Model (2001) 1.09

Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem J (2002) 1.07

Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J (2002) 1.06

High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol Endocrinol (2004) 1.01

High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation. Mol Endocrinol (1997) 1.01

The constitution of a progesterone response element. Mol Endocrinol (1993) 1.00

The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J Biol Chem (2004) 0.99

Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. J Mol Biol (2005) 0.98

The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol (1998) 0.97

The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J Biol Chem (2002) 0.95

The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation. Biochem Biophys Res Commun (1995) 0.93

Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor. Biochemistry (1999) 0.91

NMR spectroscopic studies of the DNA-binding domain of the monomer-binding nuclear orphan receptor, human estrogen related receptor-2. The carboxyl-terminal extension to the zinc-finger region is unstructured in the free form of the protein. J Biol Chem (1997) 0.86

The role of the T-box for the function of the vitamin D receptor on different types of response elements. Nucleic Acids Res (1998) 0.85

Articles by these authors

Structural basis for the histone chaperone activity of Asf1. Cell (2006) 4.95

Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc Natl Acad Sci U S A (2010) 2.24

Structural basis and specificity of acyl-homoserine lactone signal production in bacterial quorum sensing. Mol Cell (2002) 1.92

The histone shuffle: histone chaperones in an energetic dance. Trends Biochem Sci (2010) 1.89

ASF1 binds to a heterodimer of histones H3 and H4: a two-step mechanism for the assembly of the H3-H4 heterotetramer on DNA. Biochemistry (2005) 1.70

Specificity of acyl-homoserine lactone synthases examined by mass spectrometry. J Bacteriol (2006) 1.57

The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol (2006) 1.56

DNA binding and bending by HMG boxes: energetic determinants of specificity. J Mol Biol (2004) 1.46

Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol (2005) 1.42

Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol Cell Biol (2005) 1.41

Structure of the Pseudomonas aeruginosa acyl-homoserinelactone synthase LasI. Mol Microbiol (2004) 1.40

Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med (2007) 1.36

Transcriptional response of the murine mammary gland to acute progesterone exposure. Endocrinology (2008) 1.33

Quorum-sensing control of antibiotic synthesis in Burkholderia thailandensis. J Bacteriol (2009) 1.33

Mutational analysis of Burkholderia thailandensis quorum sensing and self-aggregation. J Bacteriol (2009) 1.28

Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril (2005) 1.26

Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol Cell Biol (2005) 1.25

Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol Cell Biol (2002) 1.23

Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids (2003) 1.23

Structural analysis and DNA binding of the HMG domains of the human mitochondrial transcription factor A. Nucleic Acids Res (2009) 1.21

The biology of progesterone receptor in the normal mammary gland and in breast cancer. Mol Cell Endocrinol (2011) 1.19

The activity of the histone chaperone yeast Asf1 in the assembly and disassembly of histone H3/H4-DNA complexes. Nucleic Acids Res (2011) 1.19

The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids (2008) 1.18

Proteomic analysis of coregulators bound to ERα on DNA and nucleosomes reveals coregulator dynamics. Mol Cell (2013) 1.17

A complex LuxR-LuxI type quorum sensing network in a roseobacterial marine sponge symbiont activates flagellar motility and inhibits biofilm formation. Mol Microbiol (2012) 1.17

Transcriptional activation by mitochondrial transcription factor A involves preferential distortion of promoter DNA. Nucleic Acids Res (2011) 1.15

Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids (2002) 1.15

DNA binding of a non-sequence-specific HMG-D protein is entropy driven with a substantial non-electrostatic contribution. J Mol Biol (2003) 1.13

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol (2007) 1.12

Crystal structure of QscR, a Pseudomonas aeruginosa quorum sensing signal receptor. Proc Natl Acad Sci U S A (2011) 1.12

The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity. Nucleic Acids Res (2003) 1.07

The Burkholderia mallei BmaR3-BmaI3 quorum-sensing system produces and responds to N-3-hydroxy-octanoyl homoserine lactone. J Bacteriol (2008) 1.06

The high mobility group box: the ultimate utility player of a cell. Trends Biochem Sci (2012) 1.05

CAF-1-induced oligomerization of histones H3/H4 and mutually exclusive interactions with Asf1 guide H3/H4 transitions among histone chaperones and DNA. Nucleic Acids Res (2012) 1.05

Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. Mol Endocrinol (2006) 1.03

A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab (2004) 1.03

The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab (2013) 1.01

Retracted Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol Cell Biol (2006) 1.01

Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem (2009) 1.01

Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem (2004) 1.00

Mechanism of action of progesterone antagonists. Exp Biol Med (Maywood) (2002) 1.00

Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. Mol Endocrinol (2013) 1.00

The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J Biol Chem (2004) 0.99

N-(3-hydroxyhexanoyl)-l-homoserine lactone is the biologically relevant quormone that regulates the phz operon of Pseudomonas chlororaphis strain 30-84. Appl Environ Microbiol (2007) 0.98

Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol (2006) 0.97

Differential modulation of DNA conformation by estrogen receptors alpha and beta. J Biol Chem (2001) 0.96

A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J Biol Chem (2009) 0.96

The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J Biol Chem (2002) 0.95

Structural and functional analysis of domains of the progesterone receptor. Mol Cell Endocrinol (2011) 0.95

Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer. Sci Transl Med (2014) 0.94

Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res (2008) 0.94

Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges. Mol Endocrinol (2013) 0.94

Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol Cell Biol (2005) 0.93

Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding. Proc Natl Acad Sci U S A (2010) 0.93

The Aurora A and Aurora B protein kinases: a single amino acid difference controls intrinsic activity and activation by TPX2. Cell Cycle (2005) 0.91

Evaluation of the Virus Counter® for rapid baculovirus quantitation. J Virol Methods (2010) 0.89

Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. Mol Endocrinol (2011) 0.89

Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. Cancer Res (2007) 0.89

Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain. PLoS One (2011) 0.86

Quorum-sensing signal synthesis by the Yersinia pestis acyl-homoserine lactone synthase YspI. J Bacteriol (2006) 0.86

Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa. J Mol Biol (2007) 0.85

Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs). Semin Reprod Med (2005) 0.85

Structures of liganded and unliganded RsrI N6-adenine DNA methyltransferase: a distinct orientation for active cofactor binding. J Biol Chem (2003) 0.85

Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400. Mol Endocrinol (2009) 0.85

Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. Exp Hematol (2006) 0.84

Histone transfer among chaperones. Biochem Soc Trans (2012) 0.84

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. Mol Endocrinol (2010) 0.84

Centrosomal localization of cyclins E and A: structural similarities and functional differences. Cell Cycle (2011) 0.83

Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells. J Steroid Biochem Mol Biol (2009) 0.83

Analysis of histone chaperone antisilencing function 1 interactions. Methods Enzymol (2012) 0.82

Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding. J Biol Chem (2013) 0.82

Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci U S A (2014) 0.81

The C terminus of the histone chaperone Asf1 cross-links to histone H3 in yeast and promotes interaction with histones H3 and H4. Mol Cell Biol (2012) 0.80

Crystallization of Pseudomonas aeruginosa AHL synthase LasI using beta-turn crystal engineering. Acta Crystallogr D Biol Crystallogr (2004) 0.80

The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific. Steroids (2013) 0.80

Synthesis and antiprogestational properties of novel 17-fluorinated steroids. Steroids (2013) 0.79

Bayesian analysis of high-throughput quantitative measurement of protein-DNA interactions. PLoS One (2011) 0.79

Finally! A model for progesterone receptor action in normal human breast. Endocrinology (2009) 0.79

A new GNAT in bacterial signaling? Structure (2006) 0.78

Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence. Breast Cancer Res Treat (2012) 0.78

Methylseleninic acid is a novel suppressor of aromatase expression. J Endocrinol (2011) 0.77

Genetic and structure-function studies of missense mutations in human endothelial lipase. PLoS One (2013) 0.75

Reversed-phase ion-pair liquid chromatography method for purification of duplex DNA with single base pair resolution. Nucleic Acids Res (2013) 0.75

Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol (2016) 0.75

Watching flipping junctions. Nat Struct Biol (2003) 0.75

A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo. Mol Endocrinol (2014) 0.75

Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis. PLoS One (2013) 0.75

Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression. Blood Coagul Fibrinolysis (2003) 0.75